A Study for Patients With Type 1 Diabetes Mellitus

NCT00447213 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin glargine
DRUG: Human Insulin Inhalation Powder
DRUG: Injectable Insulin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]